CLOs on the Move


 
MY01 is a state-of-the-art medical device geared towards aiding in the detection of Compartment Syndrome (CS); a limb-threatening muscle condition that occurs within 48 hours following trauma. Currently, ACS is diagnosed based on subjective and unreliable outcomes like pain (known as 6 P`s), which when present cannot confirm the diagnosis in time for effective intervention. This leads to increased complications (muscle necrosis/amputation) and costs the US healthcare system more than $2.25 B annually. MY01 is capitalizing on a proven correlation between sustained increase in Intramuscular pressures and ACS for objective, early diagnosis. MY01 operationalizes muscular pressure monitoring into a simple, ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.my01.io
  • 400 Boul de Maisonneuve Ouest Suite 700
    Montréal, QC CAN H3A 1L4
  • Phone: 855.799.6901

Executives

Name Title Contact Details

Similar Companies

Armm Inc

ARMM, Inc. offers high quality disposable medical devices and contract services at reasonable cost with short response times. ARMM can assist with every stage of your project. All production, manufacturing, and assembly processes are in certified clean

Brijjitco

The Brijjit™ technology is created and produced by BrijjitCo, a limited liability company based in Atlanta, GA.. Our founder and CEO, Felmont (Monte) F. Eaves, III, MD, FACS, is a highly credentialed plastic surgeon who saw a gap and was determined to bridge it. No, we`re not a huge company. Yet. But we are singularly focused on improving the surgical landscape with breakthrough technologies that will support surgeons everywhere in their goal to deliver the most spectacular outcomes. We strongly believe that Brijjit™ is just such an innovation, and we don`t plan to stop there!

XII Medical

Minimally Invasive Technology for Obstructive Sleep Apnea

Cyrano Therapeutics

The Cyrano team has developed a unique, proprietary intranasal product to restore function in patients with a chronic loss of taste and smell. This is a condition affecting at least 14 million people in the US and a similar number in Europe, having a significant impact on safety, quality of life and well-being.

FusionOne

FusionOne is a Roselle, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.